Article
Combination therapy of bevacizumab and galunisertib extends TVN time window.
Molecular therapy. Oncology · 2024 · L. Yin
Key facts
| Title | Combination therapy of bevacizumab and galunisertib extends TVN time window. |
|---|---|
| First author | L. Yin |
| Journal | Molecular therapy. Oncology |
| Published | Oct 15, 2024 |
| DOI | 10.1016/j.omton.2024.200888 |
| PubMed ID | 39483214 |
| PMC ID | PMC11525123 |
| Devices mentioned | 200888 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1